APO-Candesartan HCTZ 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

hydrochlorothiazide, Quantity: 12.5 mg; candesartan cilexetil, Quantity: 32 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Candesartan cilexetil,Hydrochlorothiazide

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: carmellose calcium; iron oxide yellow; magnesium stearate; lactose monohydrate; hyprolose; maize starch; triacetin

Administration route:

Oral

Units in package:

100

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

The treatment of hypertension. Treatment should not be initiated with this fixed dose combination.

Product summary:

Visual Identification: Yellow, capsule shaped, scored biconvex tablets, engraved APO with Notch on one side and 32 bisect 12.5 on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2013-05-13